Title :

Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis

Author(s) :

Kritikos, Antonios [Auteur]
Poissy, Julien [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Croxatto, Antony [Auteur]
Bochud, Pierre-Yves [Auteur]
Pagani, Jean-Luc [Auteur]
Lamoth, Frederic [Auteur]

Journal title :

Journal of clinical microbiology

Abbreviated title :

J Clin Microbiol

Volume number :

58

Publisher :

American Society for Microbiology

Publication date :

2020-05-26

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

The 1,3-beta- d -glucan (BDG) test is used for the diagnosis of invasive candidiasis (IC) in intensive care units (ICUs). However, its utility for patient management is unclear. This study assessed ...
Show more >The 1,3-beta- d -glucan (BDG) test is used for the diagnosis of invasive candidiasis (IC) in intensive care units (ICUs). However, its utility for patient management is unclear. This study assessed the impact of BDG test results on therapeutic decisions. This was a single-center observational study conducted in an ICU over two 6-month periods. All BDG test requests for the diagnosis of IC were analyzed. Before the second period, the ICU physicians received a pocket card instruction (algorithm) for targeted BDG testing in high-risk patients.Show less >

Language :

Anglais

Audience :

Non spécifiée

Administrative institution(s) :

Université de Lille
CNRS

Collections :

• Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576

Research team(s) :

Glycobiology in fungal Pathogenesis and Clinical Applications

Submission date :

2021-07-15T07:58:43Z